Helius Medical Technologies Inc (HSDT)

May 17, 2025

Helius Medical Technologies Secures Key Reimbursement Approval for PoNS Device - MyChesCo

May 17, 2025

May 12, 2025

United Healthcare covers PoNS Device for MS patients By Investing.com - Investing.com South Africa

May 12, 2025

May 12, 2025

HSDT Gains Reimbursement Approval for PoNS Device from Major Ins - GuruFocus

May 12, 2025

May 12, 2025

United Healthcare covers PoNS Device for MS patients - Investing.com

May 12, 2025

May 12, 2025

Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device - The Manila Times

May 12, 2025

May 12, 2025

Helius Medical Technologies, Inc. Announces Reimbursement - GlobeNewswire

May 12, 2025

May 10, 2025

HSDT FINAL SEPT. 9 DEADLINE, ROSEN, A TOP RANKED LAW FIRM, Reminds Helius Medical Technologies, Inc. Investors of Important Monday Deadline in Securities Class ActionHSDT - ACCESS Newswire

May 10, 2025

May 10, 2025

Helius Medical Technologies (HSDT) to Release Quarterly Earnings on Monday - Defense World

May 10, 2025

May 10, 2025

Helius Medical Technologies (HSDT) Expected to Announce Earnings on Monday - The AM Reporter

May 10, 2025

May 05, 2025

Newtown-Based Helius Medical Technologies Issues Reverse Stock Split - BUCKSCO.Today

May 05, 2025

May 01, 2025

Helius Medical Technologies announces 1-for-15 reverse stock split - MSN

May 01, 2025

May 01, 2025

HELIUS MEDICAL TECHNOLOGIES, INC. SEC 10-Q Report - TradingView

May 01, 2025

May 01, 2025

Helius Medical Technologies initiates 1-for-15 reverse stock split to meet Nasdaq requirements - The Business Journals

May 01, 2025

Apr 30, 2025

Helius Medical (HSDT) Initiates 1-for-15 Reverse Stock Split | H - GuruFocus

Apr 30, 2025

Apr 30, 2025

Helius Announces 1-for-15 Reverse Stock Split To Regain Nasdaq Compliance - Nasdaq

Apr 30, 2025

Apr 30, 2025

HSDT stock touches 52-week low at $0.26 amid sharp annual decline - Investing.com

Apr 30, 2025

Apr 30, 2025

Helius Medical Technologies Announces Reverse Stock Split - marketscreener.com

Apr 30, 2025

Apr 30, 2025

Helius Medical announces 1-for-15 reverse stock split By Investing.com - Investing.com India

Apr 30, 2025

Apr 30, 2025

Helius Medical announces 1-for-15 reverse stock split - Investing.com

Apr 30, 2025

Apr 30, 2025

Helius Medical's 1:15 Reverse Split Aims to Meet Nasdaq Requirements: What Shareholders Must Know - Stock Titan

Apr 30, 2025

Apr 26, 2025

Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market - The Globe and Mail

Apr 26, 2025

Apr 25, 2025

Helius Medical secures $1.3M in private placement - Investing.com Australia

Apr 25, 2025

Apr 25, 2025

Helius Medical secures $1.3M in private placement By Investing.com - Investing.com South Africa

Apr 25, 2025

Apr 05, 2025

HELIUS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Helius Medical Technologies, Inc. To Contact The Firm - ACCESS Newswire

Apr 05, 2025

Apr 04, 2025

Helius Medical Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - Quantisnow

Apr 04, 2025

Apr 04, 2025

HSDT stock plunges to 52-week low of $0.37 amid steep decline - Investing.com

Apr 04, 2025

Apr 02, 2025

Virtu Financial LLC Purchases New Shares in Helius Medical Technologies, Inc. (NASDAQ:HSDT) - Defense World

Apr 02, 2025

Mar 31, 2025

Helius Medical Unveils Revelation Neuro to Pioneer AI-Powered Neurorehabilitation - MSN

Mar 31, 2025

Mar 28, 2025

Helius Medical Creates Brain-Computer Interface Subsidiary - Medical Product Outsourcing

Mar 28, 2025

Mar 26, 2025

SEC Form 424B5 filed by Helius Medical Technologies Inc. - Quantisnow

Mar 26, 2025

Mar 26, 2025

Helius Medical Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025

Mar 25, 2025

Helius Medical Technologies Inc. (HSDT) reports earnings - Quartz

Mar 25, 2025

Mar 24, 2025

Chronic Traumatic Encephalopathy Pipeline 2025: MOA, ROA, - openPR.com

Mar 24, 2025

Mar 24, 2025

Helius Medical Technologies Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView

Mar 24, 2025

Mar 24, 2025

Chronic Traumatic Encephalopathy Treatment Market Size in 7MM - openPR.com

Mar 24, 2025

Mar 22, 2025

Helius Medical Technologies Reports Positive Preliminary Results from PoNSTEP Study - MSN

Mar 22, 2025

Mar 19, 2025

Helius Medical Technologies (HSDT) Expected to Announce Quarterly Earnings on Wednesday - The AM Reporter

Mar 19, 2025

Mar 15, 2025

Helius Medical Secures First Insurance Reimbursement for PoNS Device - MSN

Mar 15, 2025

Mar 14, 2025

Helius joins BCI landscape with new subsidiary - Yahoo

Mar 14, 2025

Mar 13, 2025

Helius Medical launches AI-driven BCI subsidiary - Investing.com Australia

Mar 13, 2025

Mar 13, 2025

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface ('BCI”) Technology Private Subsidiary - The Manila Times

Mar 13, 2025

Mar 13, 2025

Helius Medical launches AI-driven BCI subsidiary By Investing.com - Investing.com UK

Mar 13, 2025

Mar 13, 2025

Helius Medical Technologies, Inc. Announces the - GlobeNewswire

Mar 13, 2025

Mar 13, 2025

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer ... - Bluefield Daily Telegraph

Mar 13, 2025

Mar 13, 2025

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary - TradingView

Mar 13, 2025

Mar 13, 2025

Helius Medical's New AI Brain Interface Venture Aims to Transform Neurorehabilitation Without Surgery - StockTitan

Mar 13, 2025

Mar 11, 2025

Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device - The Manila Times

Mar 11, 2025